Cargando…
Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
The development of new immunosuppressive drugs for kidney transplantation resulted both in better short-term outcomes and in decreased metabolic, cardiovascular, and nephrotoxicity risk. Belatacept belongs to a new class of immunosuppressive drugs that selectively inhibits T-cell activation by preve...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468025/ https://www.ncbi.nlm.nih.gov/pubmed/23055693 http://dx.doi.org/10.2147/BTT.S27565 |